BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 11:44:00 AM | Browse: 809 | Download: 949
 |
Received |
|
2013-11-09 11:29 |
 |
Peer-Review Started |
|
2013-11-09 16:30 |
 |
To Make the First Decision |
|
2013-12-13 13:37 |
 |
Return for Revision |
|
2013-12-16 16:54 |
 |
Revised |
|
2014-01-08 09:00 |
 |
Second Decision |
|
2014-01-20 09:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-20 10:12 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-05-07 14:40 |
 |
Publish the Manuscript Online |
|
2014-05-12 18:06 |
Category |
Oncology |
Manuscript Type |
Autobiography |
Article Title |
mRNA expression of DOK1-6 in human breast cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tamara Ghanem, James Bracken, Abdul Kasem, Wen G Jiang and Kefah Mokbel |
Funding Agency and Grant Number |
|
Corresponding Author |
Kefah Mokbel, Professor, London Breast Institute, Princess Grace Hospital, 42-52 Nottingham Pl, London, W1U 5NY, United Kingdom. kefahmokbel@hotmail.com |
Key Words |
Adaptor protein; Breast cancer; Downstream of tyrosine kinase-2; Downstream of tyrosine kinase-6; Mitogen-activated protein kinase; Tyrosine kinase; Tumour suppressor |
Core Tip |
Several members of the downstream of tyrosine kinase (DOK) protein family are identified as modulators of cell proliferation/growth pathways. In addition deregulation of specific DOK members has been associated with specific cancers. This study identifies DOK-2 and DOK-6 as potential tumor suppressors in breast cancer. |
Publish Date |
2014-05-12 18:06 |
Citation |
Ghanem T, Bracken J, Kasem A, Jiang WG, Mokbel K. mRNA expression of DOK1-6 in human breast cancer. World J Clin Oncol 2014; 5(2): 156-163 |
URL |
http://www.wjgnet.com/2218-4333/full/v5/i2/156.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v5.i2.156 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345